What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to provide advance notice to investors about an upcoming interview session at the Barclays Global Healthcare Conference where UnitedHealth Group's senior leaders will discuss the company's strategy, market positions, recent results, and outlook.

Where and when can investors access the presentation?

The interview is scheduled for Tuesday, March 12, 2019, at 9:30 a.m. Eastern Time. Investors can access a live audio webcast of the presentation through the Investors page of UnitedHealth Group's website at www.unitedhealthgroup.com.

What topics will be covered during the conference presentation?

The senior leaders will discuss UnitedHealth Group's strategy, its competitive market positions, recent financial results, and their expectations for the company's various end markets.

Is the information presented at the conference considered 'filed' with the SEC?

Under Item 7.01 Regulation FD Disclosure, the information presented is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated into other company filings, unless specifically stated otherwise in a future filing.

UNH 8-K: Regulation FD

Summary

UnitedHealth Group Inc. (UNH) has announced that senior leadership will participate in an interview at the Barclays Global Healthcare Conference on March 12, 2019. The discussion will cover the company's strategic direction, market standing, recent performance, and outlook for its various end markets. This event presents an opportunity for investors to gain deeper insights into UNH's business operations and future prospects directly from its management team.

Key Highlights

1Senior leaders from UnitedHealth Group will participate in an interview at the Barclays Global Healthcare Conference.
2The conference is scheduled for March 12, 2019, in Miami, Florida.
3Key discussion points will include company strategy, market positions, recent results, and expectations for end markets.
4A live audio webcast of the presentation will be available on the company's investor website.
5This disclosure is made under Regulation FD, ensuring broad public dissemination of material information.
6Information presented is not deemed 'filed' for Section 18 purposes but may be incorporated by reference in future filings if explicitly stated.

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Mar 8, 2019)

Summary

Key Highlights

Frequently Asked Questions